Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Vertex Pharmaceuticals is anchored by cystic fibrosis as launches lag, JOURNAVX and CASGEVY add little revenue, and growth is ...

OCZ Technology Introduces the High Performance Vertex Series Solid State Drive Delivering on the Promise of Ultimate Performance and Affordability Sunnyvale, CA—OCZ Technology Group, Inc., a worldwide ...

In its upcoming report, Vertex Pharmaceuticals (VRTX) is predicted by Wall Street analysts to post quarterly earnings of $4.04 per share, reflecting an increase of 3.9% compared to the same period ...

Back in April, we reviewed OCZ's Vertex 4 SSD and claimed that its Indilinx 2 controller had been successful in competing with SandForce, though, not in beating it. In May, however, we announced that ...

William Blair analyst Jake Roberge has maintained their bullish stance on VERX stock, giving a Buy rating today. Jake Roberge has given his Buy rating due to a combination of factors including ...

Application monitoring and security platform provider Datadog Inc. said today it’s expanding its partnership with Google Cloud, becoming one of the first artificial intelligence observability partners ...